Francesco Bono
Francesco Bono has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Huong Elena Tran
Radiomics GSTeP Core Research Facility, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
2 shared publications Luca Boldrini
UOC Radioterapia Oncologica, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Rome, Italy; Radiomics Core Research Facility, Gemelli Science and Technology Park, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Rome, Italy
2 shared publicationsMaria Antonietta Gambacorta
UOC Radioterapia Oncologica, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Rome, Italy; Istituto di Radiologia, Università Cattolica Del Sacro Cuore, Rome, Italy
2 shared publicationsA. Romano
Department of Radiation Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
1 shared publication- Angela Romano
Department of Diagnostic Imaging and Oncological Radiotherapy, Agostino Gemelli University Hospital Foundation, IRCCS, 00168 Rome, Italy
1 shared publication Christian Goelz
Department of Medicine I, LMU University Hospital, LMU Munich, Munich, Germany
1 shared publication
Latest Publications
- Open Access
- 4 August 2026
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 223, 111719
Early regression index-guided adaptive dose escalation in locally advanced rectal cancer: results of the prospective THUNDER-2 trial
- 4 August 2026
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 223, 111719
Open AccessEarly regression index-guided adaptive dose escalation in locally advanced rectal cancer: results of the prospective THUNDER-2 trial
- Open Access
- 15 November 2024
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 51 (7) , 109463
Response prediction for neoadjuvant treatment in locally advanced rectal cancer patients-improvement in decision-making: A systematic review
- 15 November 2024
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 51 (7) , 109463
Open AccessResponse prediction for neoadjuvant treatment in locally advanced rectal cancer patients-improvement in decision-making: A systematic review
- Open Access
- 14 October 2024
- Published by Springer Nature in npj Digital Medicine
- Vol. 7 (1) , 1-12
Privacy-friendly evaluation of patient data with secure multiparty computation in a European pilot study
In multicentric studies, data sharing between institutions might negatively impact patient privacy or data security. An alternative is federated analysis by secure multiparty computation. This pilot study demonstrates an architecture and implementation addressing both technical challenges and legal difficulties in the particularly demanding setting of clinical research on cancer patients within the strict European regulation on patient privacy and data protection: 24 patients from LMU University Hospital in Munich, Germany, and 24 patients from Policlinico Universitario Fondazione Agostino Gemelli, Rome, Italy, were treated for adrenal gland metastasis with typically 40 Gy in 3 or 5 fractions of online-adaptive radiotherapy guided by real-time MR. High local control (21% complete remission, 27% partial remission, 40% stable disease) and low toxicity (73% reporting no toxicity) were observed. Median overall survival was 19 months. Federated analysis was found to improve clinical science through privacy-friendly evaluation of patient data in the European health data space.
- 14 October 2024
- Published by Springer Nature in npj Digital Medicine
- Vol. 7 (1) , 1-12
Open AccessPrivacy-friendly evaluation of patient data with secure multiparty computation in a European pilot study
In multicentric studies, data sharing between institutions might negatively impact patient privacy or data security. An alternative is federated analysis by secure multiparty computation. This pilot study demonstrates an architecture and implementation addressing both technical challenges and legal difficulties in the particularly demanding setting of clinical research on cancer patients within the strict European regulation on patient privacy and data protection: 24 patients from LMU University Hospital in Munich, Germany, and 24 patients from Policlinico Universitario Fondazione Agostino Gemelli, Rome, Italy, were treated for adrenal gland metastasis with typically 40 Gy in 3 or 5 fractions of online-adaptive radiotherapy guided by real-time MR. High local control (21% complete remission, 27% partial remission, 40% stable disease) and low toxicity (73% reporting no toxicity) were observed. Median overall survival was 19 months. Federated analysis was found to improve clinical science through privacy-friendly evaluation of patient data in the European health data space.